Loading your page…
Loading your page…
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADVATE 1000 IU | Antihemophilic factor | Saudi Arabia | Authorised | |
| ADVATE 250 IU | Antihemophilic factor | Saudi Arabia | Authorised | |
| ADVATE 500 IU | Antihemophilic factor | Saudi Arabia | Authorised | |
| ADYNOVATE | Antihemophilic factor, Pegylated human sequence recombinant | Saudi Arabia | Authorised | |
| OLIMEL N9 emulsion for infusion | Glucose, Olive oil, Soya oil, Alanine, Arginine, Lysine, Amino acids, Phenylalanine, Glycine, Valine, Proline, Glutamic acid, Threonine, Isoleucine, Methionine, Serine, Histidine, Aspartic acid, Tryptophan, Tyrosine | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 5 | 5 | 0 | CompaniesAll medicines |
Also in the registers of Brazil
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.